The evolution of an oral heparin dosing solution

Drugs of the Future

Volumn 22, Issue 8, 1997, Pages 885-891

  Leone Bay, Andrea ^a   Leipold, Harry ^a   Agarwal, Rajesh ^a   Rivera, Theresa ^a   Baughman, Robert A ^a  

^a Emisphere Technologies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; HEPARIN; N [8 (2 HYDROXYBENZOYL)AMINO]CAPRYLATE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; DRUG DELIVERY SYSTEM; DRUG MONITORING; DRUG SAFETY; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; MONKEY; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RAT; REVIEW;

EID: 0030701831     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.08.425700     Document Type: Review

References (22)

1. Gallus, A.S. Anticoagulants in the prevention of venous thromboembolism. Baillieres Clin Haematol 1990, 3: 651-84.
2. Hardman, J.B., Limbird, L.E. Anticoagulants, thrombolytic, and antiplatelet drugs. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Macmillan: New York 1996, 1344-6.
3. Griffin, J.P., D'Arcy, P.F., Speirs, C.J. Anticoagulants. In: A Manual of Adverse Drug Interactions. John Wright: London 1988, 137-58.
4. DalPozzo, A., Acquasaliente, M., Geron, M.R. New heparin complexes active by intestinal absorption. I. Multiple ion pairs with basic organic compounds. Thromb Res 1989, 56: 119-24.
5. Caramazza, I., D'Atri, G., Bossi, M.L., DePonti, F., D'Angelo, L., Crema, A. Intraduodenal absorption of the new UF-heparin salt ITF 1057 in the conscions dog. Thromb Res 1991, 62: 785-9.
6. Morton, A.K., Edwards, H.E., Allen, J.C., Phillips, G.O. An evaluation of the oral administration of commercial and fractionated heparin samples in rats. Int J Pharm 1982, 9: 321-35.
7. Sue, T.K., Jaque, L.B., Yuen, E. Effects of acidity, cations, and alcoholic fractionation on absorption of heparin from the gastrointestinal tract. Can J Physiol Pharmacol 1976, 54: 613-8.
8. Engel, R.H., Riggi, S.J. Intestinal absorption of heparin facilitated by sulphated or sulfonated surfactants. Proc Soc Exp Biol Med 1969, 130: 706-10.
9. Guarini, S., Ferrari, W. Olive oil-provoked, bile-dependent absorption of heparin from the gastrointestinal tract in rats. Pharm Res Commun 1985, 17: 685-94.
10. Ueno, M., Nakasake, T., Horikoshi, I., Sakuragawa, N. Oral administration of liposomally-entrapped heparin to beagle dogs. Chem Pharm Bull 1982, 30: 2245-7.
11. Windsor, E., Cronheim, G.E. Gastrointestinal absorption of heparin and synthetic heparinoids. Nature 1961, 190: 263-4.
12. Tidball, C.S., Lipman, R.I. Enhancement of jejunal absorption of heparinoid sodium ethylenediaminetetraacetate in the dog. Proc Soc Exp Biol Med 1962, 111: 713-5.
13. Leone-Bay, A., Ho, K.K., Agarwal, R. et al. 4-[4-(2-Hydroxybenzoyl)aminophenyl]butyric acid as a novel oral delivery agent for recombinant human growth hormone. J Med Chem 1996, 39: 2571-8.
14. Leone-Bay, A., Santiago, N., Achan, D. et al. N-Acylated α-amino acids as novel oral delivery agents for proteins. J Med Chem 1995, 38: 4263-9.
15. Leone-Bay, A., Leipold, H., Paton, D., Milstein, S., Baughman, R.A. Oral delivery of rhGH: Preliminary mechanistic considerations. Drug News Perspect 1996, 9: 586-91.
16. Leone-Bay, A., Paton, D., Variano, B. et al. Acylated non-α-amino acids as novel agents for the oral delivery of heparin sodium, USP. J Controlled Release 1997, accepted for publication.
17. Steiner, S., Rosen, R. Delivery system for pharmacological agents encapsulated with proteinoids. US 4925673, 1990.
18. Hartmann, M., Brand, M.C., Dose, K. Formation of specific amino acid sequences during the polymerization of amino acids. Biosystems 1981, 13: 141-7.
19. Nakashima, T., Juneck, J.R., Fox, S.W., Lederer, E., Das, B.C. A test for randomness in peptides isolated from a thermal polyamino acid. Int J Quantum Chem 1977, QBS4: 65-72.
20. Milstein, S.J., Barentsevitch, E.N., Grechanovski, V.A., Sarubbi, D.J. pH-Dependent microspheres from modified soybean protein hydrolysate. J Microencapsul 1996, 13: 651-65.
21. Rivera, T., Leone-Bay, A., Paton, D.P., Leipold, H., Baughman, R.A. Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]cparylate: Pharmacological considerations. Pharm Res, accepted for publication.
22. Wallin, A., Jaques, L.B. Melachromasia: an explanation of the color change produced in dyes by heparin and other substances. Thromb Res 1973, 2: 337-82.